Cargando…
Peroxisome proliferator-activated receptor gamma ligand-mediated apoptosis of hepatocellular carcinoma cells depends upon modulation of PI3Kinase pathway independent of Akt
BACKGROUND: Ligands of Peroxisome proliferator-activated receptor gamma (PPARγ) can inhibit growth and promote apoptosis in various cancer cells, and thus have the potential to be utilized as anticancer drugs. This potential however, has been seriously challenged by observations that they can lead t...
Autores principales: | Mishra, Prajna, Paramasivam, Suresh K, Thylur, Ramesh P, Rana, Ajay, Rana, Basabi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009957/ https://www.ncbi.nlm.nih.gov/pubmed/21144036 http://dx.doi.org/10.1186/1750-2187-5-20 |
Ejemplares similares
-
Glycogen Synthase Kinase-3beta regulates Snail and beta-catenin during gastrin-induced migration of gastric cancer cells
por: Mishra, Prajna, et al.
Publicado: (2010) -
Transcription Factors in Cancer Development and Therapy
por: Vishnoi, Kanchan, et al.
Publicado: (2020) -
Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma
por: Vishnoi, Kanchan, et al.
Publicado: (2022) -
Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma
por: Hsu, Hui-Tzu, et al.
Publicado: (2014) -
Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies
por: Garcia-Bates, Tatiana M., et al.
Publicado: (2008)